Searched for
MIGRAINE DRUG
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Pfizer launches new medication for migraine treatmentIn a significant breakthrough for migraine sufferers in India, Pfizer has launched Rimegepant ODT, an innovative oral tablet that dissolves...
- Apollo neurologist shares 5 ‘zero-cost’ and ‘side-effect-free' tips to manage migraineMigraine sufferers can find relief through simple lifestyle changes. Dr Sudhir Kumar, a neurologist, highlights that good sleep, stress man...
- Dr Reddy's launches migraine management device in EuropeThe launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement. Nerivio is ap...
- Dr Reddy's rolls out wearable device for migraine managementDr Reddy's Laboratories has introduced Nerivio, a wearable therapy device for drug-free migraine management, approved by the US FDA. Nerivi...
- Woke up with a headache? Coffee, smartphones, medication overuse could be the culpritsMigraines are also a common morning headache culprit.
- Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal sprayThe drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
- Dr Reddy's may file two new drugs with FDA by 2019The city-based pharma company is expected to file the New Drug Application (NDA)with US Food and Drug Administration with regard the migrai...
- Zydus Cadila gets USFDA nod to market migraine drugZydus Cadila has received the final approval from the USFDA to market Eletriptan Hydrobromide tablets, 20 mg (base) and 40 mg (base).
- Panacea inks pact with UNICEF,gets USFDA nod for migraine drugPanacea's product is equivalent to Merck & Co's Maxalt-MLT tablets. The drug has annual sales for around USD 60 million in the US market.
- Alembic Pharma gets US FDA nod for anti-migraine drug"The company has received approval from the USFDA for its Abbreviated New Drug Application for Zolmitriptan Orally Disintegrating Tablets, ...
- Aurobindo Pharma gets USFDA nod for generic migraine drugThe company's product is the generic equivalent of IPR Pharmaceuticals' Zomig, which is used in the treatment of migraine in adults.
- Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
- Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...
- Jubilant Life gets USFDA nod for anti-migraine tabletsJubilant Life Sciences today said it has received US health regulator's nod to market its generic zolmitriptan orally disintegrating tablet...
- Strides gets US approval for migraine drugDrug maker Strides Arcolab on Monday said US health regulator Food and Drug Administration has given its nod for sale of Sumatriptan Succin...
- Ranbaxy up 3% on USFDA nod for migraine drugAmid the general weakness in the market, shares of Ranbaxy Laboratories bucked the trend after it received the US Food and Drug Administrat...
- Govt to share Lupin's migraineThe government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...
Load More
